AI Case Study
Huashan Hospital develops a robotics based radiosurgery procedure to treat inoperable intracranial tumour sizes achieving 55% reduction on average
The robotic radio-surgery system developed by Accuray uses AI to conduct automatic, real-time tumour tracking and motion management and uses this data to determine the procedure. Huashan Hospital in China is employing this at their CyberKnife centre which has been testing the radio surgery system in treating inoperable brain metastases.
Healthcare Providers And Services
"CyberKnife, a radio-surgery system that uses AI to offer highly precise, non-surgical treatment for tumors and lesions anywhere in the body — including the prostate, lung, brain, spine, liver, pancreas and kidney, It also records automatic, real-time tumor tracking and motion management. The Huashan CyberKnife Center was one of the earliest to apply this technology.
Achieving new level of precision has enabled them to deliver state-of-the-art treatments for a wide range of cancers and functional disorders. They have been testing this on otherwise inoperable brain tumors formed from metastasis. MRI imaging revealed an average reduction of 55.8 and 63.4 % in post-gadolinium and T2-weighted scans, respectively indicating rapid response to CyberKnife treatment for tumor shrinkage. All patients, with only one exception, showed significant clinical improvement in terms of neurologic symptoms. The project is still in Clinical trial phase."
R And D
Huashan Hospital is one of the top hospitals in China for neurosurgery.
"More than 5,500 patient treated, with about 65 percent for intracranial tumours achieving an average reduction of 55.8 and 63.4 % in post-gadolinium and T2-weighted scans indicating rapid response to CyberKnife treatment for tumour shrinkage."